Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2008 044 674.3 |
| 96 | EP file number | EAKZ | 12 15 3823.5 |
| 97 | EP publication number | EPN | 2462934 |
| 54 | Designation/title | TI | Antitumorwirkung von Temsirolimus bei papillärem Nierenzellkarzinom |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/436 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 45/06 (2006.01), A61P 35/00 (2006.01) |
| 22 | DE application date | DAT | Apr 8, 2008 |
| 96 | EP application date | EAT | Apr 8, 2008 |
| 43 | Date of first publication | OT | Jun 13, 2012 |
| Date of publication of grant | PET | Jun 8, 2016 |
| 71/73 | Applicant/owner | INH | Wyeth LLC, New York, N.Y., US |
| 72 | Inventor | IN | Dukart, Gary, Ambler, PA Pennsylvania 19002, US; Gibbons, James, Joseph, Jr., Westwood, NJ New Jersey 07675, US; Berkenblit, Anna, Needham, MA Massachusetts 02494, US; Feingold, Jay, Marshall, Wynnewood, PA Pennsylvania 19096, US |
| 74 | Representative | VTR | Kraus & Lederer PartGmbB, 80539 München, DE |
| Address for service | | Kraus & Lederer PartGmbB, 80539 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
922759 P
Apr 10, 2007
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002462934
Searchable text:
EP000002462934
Original document:
EP000002462934B1
Searchable text:
EP000002462934B1 |
| 43 | Date of first publication | EVT | Jun 13, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Jul 27, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 7, 2024
(Show all update days)(Hide all update days)- Jul 27, 2012
- Date of the first transfer into DPMAregister
|
